Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: SPAC Deals Emerge As IPO Market Goes Quiet Again

Three Firms Seize Opportunity To List Via Mergers

05 Oct 2022

• By Mandy Jackson

Finance Watch Public Company — • Source: Alamy

Related Content

Keeping Track: US FDA Clears Opioid Seglentis And Anti-Opioid Zimhi; CRLs For Revance, United; Delay For UCB

23 Oct 2021

Keeping Track: Pluvicto Boosts Novartis In Radiotherapy; BMS Builds Out IO Estate With Opdualag

25 Mar 2022

Solid Restarts DMD Gene Therapy Trial, With Encouraging Interim Data To Back It Up

16 Mar 2021

Pivotal Data Boost Omeros’ Stem Cell Transplant Product After FDA Delay

15 Jun 2021

Ipsen Targets External Innovation With Exicure Option In Rare Neurodegenerative Disorders

03 Aug 2021

PhaseBio’s Bentracimab Could Benefit From Growth In Brilinta Demand

16 Nov 2021

Deal Watch: Merck Looks To Technology Platform Partners For Cytokine Agonist Discovery, Drug Delivery

05 Nov 2021

SPAC Mergers Take Biopharmas Public, But Valuations Often Sag Post-Closing

22 Dec 2021

Deal Watch: Lilly Teams With Regor On Metabolic Disorders

10 Dec 2021

Core Global Portfolio Drives Takeda Despite Pockets Of Weakness

01 Nov 2019

Deal Watch: GSK Invests In Early-Stage Synthetic Lethality Programs At Ideaya

16 Jun 2020

Can Placenta Cells Save Severe COVID-19 Patients?

20 Apr 2020

Finance Watch: iTeos, Pandion And Aspen Show COVID-19 Hasn’t Slowed VC Deals Yet

01 Apr 2020

Vir Advances Antibodies Against COVID-19, CEO Scangos Leads BIO’s Coronavirus Outreach

20 Mar 2020

The COVID-19 Market: Keeping Up With The Changing Landscape

04 Aug 2022

Rocket Fires Up CV Gene Therapy Pipeline With Renovacor Merger

20 Sep 2022

Finance Watch: Third Harmonic Launches The Largest IPO In Months

16 Sep 2022

Idorsia’s Quviviq Needs To Rise And Shine After Slow Launch

26 Jul 2022

Valneva Confirms Step Back From COVID-19 Vaccine Development

12 Aug 2022

Finance Watch: Karuna, Cerevel And Others Benefit From Improving Biotech Sentiment

12 Aug 2022

Roivant Cuts Multiple R&D Programs As It Takes On Pfizer’s TYK2/JAK1 Inhibitor

29 Jun 2022

Related Companies

Third Harmonic Bio, Inc.

Apollomics, Inc.

Direct Biologics, LLC

Eureka Therapeutics, Inc.

Imugene Limited

Vir Biotechnology, Inc.

GSK plc

Ridgeback Biotherapeutics LP

Omeros Corporation

Rayner Intraocular Lenses Ltd.

Takeda Pharmaceutical Co. Ltd.

Valneva SE

Rocket Pharmaceuticals Inc.

Renovacor Inc.

Immunovant, Inc.

Roivant Sciences Ltd.

Solid Biosciences Inc.

AavantiBio Inc.

DMK Pharmaceuticals Corp.

Matrix Biomed, Inc.

OncoSec Medical Incorporated

Merck & Co., Inc.

Summit Therapeutics plc

Exicure, Inc.

PhaseBio Pharmaceuticals, Inc.

SFJ Pharmaceuticals, Inc

Additional Topics

Financing Business Strategies Restructuring Growth Deals Commercial Finance Watch BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.